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Abstract
Material safety data sheets (MSDSs) provide employers, employees, emergency responders, and 
the general public with basic information about the hazards associated with chemicals that are 
used in the workplace and are a part of every-day commerce. They are a primary information 
resource used by health, safety, and environmental professionals in communicating the hazards of 
chemicals and in making risk management decisions. Engineered nanomaterials represent a 
growing class of materials being manufactured and introduced into multiple business sectors. 
MSDSs were obtained from a total of 44 manufacturers using Internet search engines, and a 
simple ranking scheme was developed to evaluate the content of the data sheets. The MSDSs were 
reviewed using the ranking scheme, and categorized on the quality and completeness of 
information as it pertains to hazard identification, exposure controls, personal protective 
equipment (PPE), and toxicological information being communicated about the engineered 
nanomaterial. The ranking scheme used to evaluate the MSDSs for engineered nanomaterials was 
based on the determination that the data sheet should include information on specific physical 
properties, including particle size or particle size distribution, and physical form; specific 
toxicological and health effects; and protective measures that can be taken to control potential 
exposures. The first MSDSs for nanomaterials began to appear around 2006, so these were 
collected in the time period of 2007–2008. Comparison of MSDSs and changes over time were 
evaluated as MSDSs were obtained again in 2010–2011. The majority (67%) of the MSDSs 
obtained in 2010–2011 still provided insufficient data for communicating the potential hazards of 
engineered nanomaterials.
INTRODUCTION
Engineered nanomaterials are materials that are deliberately engineered and manufactured 
with at least one dimension between approximately 1 and 100 nanometers. This class of 
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materials includes new entities such as carbon nanotubes (CNTs), carbon nanofibers 
(CNFs), fullerenes, and quantum dots, as well as the nanoscale form of established, familiar 
materials such as titanium dioxide, gold, and silver. The combined small size and large 
surface area of these chemicals at the nanoscale produce different or unique chemical and 
physical properties. These properties include increased or novel chemical and biologic 
reactivity, electrochemical and magnetic properties, light absorption, and color. Larger scale 
particles, including those of the same chemical composition, may not exhibit the same 
properties. In addition to exhibiting different chemical properties, nanoscale material may 
also exhibit discreet, unique morphological differences from their macroscale counterparts. 
For example, Figure 1 is an electron photomicrograph of a carbon nanotube and carbon 
nanofiber. Figure 2 is an electron photomicrograph of carbon black, a high-surface-area 
form of elemental carbon formed under a controlled combustion process. Both are forms of 
carbon, but carbon nanotubes and carbon nanofibers have very different chemical and 
physical properties from those of carbon black.
The unique properties of nanoscale materials make them attractive for a wide range of 
product and process improvement applications in medicine, energy, electronics, food and 
agriculture, and general material science. Because of all the potential applications being 
explored and developed, an increasing number of nanomaterials are becoming commercially 
available. These commercially available nanomaterials include nanoscale powders, 
solutions, and suspensions of nanoscale materials, as well as composite materials and 
devices having a nanostructure. According to Lux Research, governments, corporations, and 
venture capitalists worldwide spent $11.8 billion on nanotechnology research and 
development in 2006.1 It is estimated that by 2014, $2.6 trillion in manufactured goods – or 
about 15 percent of the total global output – will incorporate nanotechnology.1
Nanomaterials are being commercially incorporated into many consumer products, 
including sporting goods, batteries, electronics, pharmaceuticals, and cosmetics. Based on 
the nanotechnology consumer product inventory maintained by the Woodrow Wilson 
Project on Emerging Nanotechnologies (PEN), there are over 1300 manufacturer-identified 
nanotechnology-based consumer products currently on the market. Data obtained in March 
2011 indicate that this inventory has grown by 521% since March 2006 (from 212 to 1317 
products).2 Although these products are finished goods with nanoparticles incorporated into 
a matrix, most likely they were all produced with use of free, unbound engineered 
nanoparticles at some stage in their manufacture. These free, unbound, engineered 
nanoparticles (nanomaterials) are being manufactured and incorporated into products in the 
United States and throughout the world, thereby providing the potential for worker 
exposure. At the same time, there isa growing body of knowledge on the potential health 
hazard of engineered nanomaterials, based on the heightened biologic activity of these 
materials in toxicologic testing.
Since 1985, the Occupational Safety and Health Administration (OSHA) has required 
chemical manufacturers and importers to perform hazard determinations and complete 
material safety data sheets (MSDSs) on chemicals determined to be hazardous [OSHA 
Hazard Communication Standard (29 CFR 1910.1200)].3 OSHA requires that MSDSs 
contain the following categories of information: (1) manufacturer’s name and contact 
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information; (2) chemical and common names of all hazardous ingredients; (3) physical/
chemical characteristics of the agent or agents; (4) carcinogenicity potential; (5) emergency 
and first aid measures; (6) primary routes of entry; (7) exposure limits and toxicity 
information established by OSHA; (8) physical hazards and reactivity data, such as 
flammability or explosive reactivity; (9) health hazard data, such as medical symptoms or 
known diseases that can be aggravated by exposure; (10) precautions for handling and use, 
including appropriate hygienic practices, and the procedures to be used to clean up leaks and 
spills; (11) applicable control measures such as engineering controls, work practices, or 
personal protective equipment (PPE); and (12) date of preparation, updates, and reviews.4–6 
Beyond requiring inclusion of this basic information, OSHA does not require or provide a 
standardized format for MSDSs. OSHA published a proposed rulemaking on September 30, 
2009, to align its Hazard Communication Standard with the Globally Harmonized System of 
Classification and Labeling of Chemicals (GHS). This proposed rule (not finalized as of 
February 10, 2012) includes 16 elements of a Safety Data Sheet (SDS); however, only 12 of 
the 16 sections will be required because 4 sections (ecological information, disposal 
considerations, transport information, and regulatory information) are outside of OSHA’s 
jurisdiction. Note that the preferred title for a MSDS will change to a Safety Data Sheet 
(SDS).
In order to convey the current OSHA-required information, many manufacturers use the 
MSDS format developed by the American National Standards Institute (ANSI) in 1993.7 
This standard was created to provide information on MSDSs in a consistent manner and to 
make it easier to find information, regardless of the author or supplier. The ANSI format 
contains all 12 of the current OSHA-required informational categories as well as four 
additional categories: (1) toxicological information; (2) transport information; (3) disposal 
information; and (4) ecological information. The proposed OSHA rule on the GHS more 
closely aligns the OSHA SDS with the ANSI format.
Under the Hazard Communication Standard, employers must provide information to their 
employees about the hazardous chemicals to which they are exposed, by means of a hazard 
communication program; labels and other forms of warning; MSDSs; and information and 
training. One of the challenges in the United States has been that this is a performance 
standard with a number of different ways of achieving compliance. Distributors and 
manufacturers are also required to transmit MSDS and labeling information to their 
customers who are employers. This “downstream flow” of information ensures that each 
subsequent employer who receives the hazardous material is apprised of the hazards. This 
element of hazard communication, while still a performance requirement, resembles what is 
being required by the European Community Regulation on chemicals and their safe use (EC 
1907/2006) through the Registration, Evaluation, Authorization and Restriction of Chemical 
substances (REACH).8
Manufacturers and importers in the European Union must provide their downstream users 
with the risk information they need to use a substance safely. This is accomplished via the 
classification and labeling system and SDSs. SDSs must also communicate information by 
using a variety of phrases that describe risk (R) or safety (S) concerns associated with the 
chemical. These statements are known as the R and S phrases. The GHS will provide a 
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framework for the classification and labeling, adding some required content for the SDS and 
changing the way that some information is currently reported on U.S. MSDSs. As the United 
States adopts the GHS, the MSDS (SDS) format and content will become more harmonized 
and will include more information on the risks and hazards of chemicals on the basis of their 
intended use.
Both OSHA and ANSI formats require information on health hazard data and control 
measures. The creation and use of engineered nanomaterials are part of an emerging 
technology, however, and a growing body of toxicological evidence suggests that 
nanomaterials behave differently than their macroscale counterparts. It stands to reason, 
then, that increased or unique chemical reactivity exhibited by nanomaterials might lead to 
increased biological activity, as well as potentially increased toxicity.
In 2005, the National Institute for Occupational Safety and Health issued a draft guidance 
document on employee exposure to nanomaterials. This document was subsequently 
updated and finalized in 2009. The document recommends preventing or reducing exposures 
with use of a hierarchy of controls, based on the increasing amount of research indicating 
adverse health effects on animals – and, therefore, potential health effects in humans.9
Experimental studies with rodents and in vitro mammalian cell cultures have shown that the 
toxicity of ultrafine particles or nanoparticles is greater than that of the same mass of larger 
particles of similar chemical composition.10–18 In laboratory animal exposure studies, 
single-walled carbon nanotubes (SWCNTs) have been observed to be more fibrogenic than 
an equal mass of either ultrafine carbon black or fine quartz.19,20 On the basis of their 
findings in mice, Shvedova et al. estimated that workers may be at risk of developing lung 
lesions if they were exposed to SWCNTs over a period of 20 days at the current OSHA 
permissible exposure limit (PEL) for graphite (5 mg/m3).19 Lam et al. provided similar 
estimates and suggested that the graphite PEL should not be used (e.g., on MSDSs) as a safe 
concentration for workers exposed to CNTs.20,21 Sargent et al. determined that in vitro 
exposure to SWCNTs can disrupt formation of the mitotic spindle within cells and could 
therefore disrupt cell division.22 In addition, it has been found that SWCNTs bind to G-C-
rich DNA sequences in the chromosomes (telomeres) that could potentially lead to 
conformational changes and destabilize the DNA.23 The toxicity of SWCNTs may be linked 
to the effects that they have on DNA, cell division, and the potential for aneuploidy.
In laboratory animal exposure studies performed by Porter et al., multiwall carbon 
nanotubes (MWCNTs) have been found to cause pulmonary fibrosis and granulomatous 
lung inflammation that persisted throughout a 56-day post-exposure period.24 Additionally, 
pleural penetration was observed at 56 days after exposure in two of four mice. However, 
the significance of this observation will require further and more extensive investigations to 
assess if pleural penetration by MWCNT results in any adverse health outcomes.
Inhalation exposure to metal nanomaterials, such as silver or gold, have demonstrated the 
materials’ potential to move easily through cell membranes, accumulate in areas outside of 
the respiratory tract, in laboratory animal exposure studies.25,26
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Occupational exposure levels (OELs) associated with the largerform bulk metal materials 
probably won’t be sufficient to protect workers from negative health effects resulting from 
exposure to the nanosized form. Generally, OELs suggest levels of exposure that most 
employees may have – up to 8 h per day, 40 h per week, for a working lifetime – without 
experiencing adverse health effects. However, not all employees will be protected from 
adverse health effects, even if their exposures are maintained below these levels. A small 
percentage may experience adverse health effects because of individual susceptibility, a pre-
existing medical condition, and/or a hypersensitivity reaction (allergy). Therefore, even 
OELs for bulk, macrosize materials are not able to provide complete protection for every 
individual.
In addition to exposure by inhalation, nanoparticles might also be introduced to the body 
through dermal absorption. Studies have indicated that nanoparticles are capable of 
penetrating the outermost layer of skin cells.27–29 Shukla et al. demonstrated that titanium 
dioxide nanoparticles produce reactive oxygen species, deplete glutathione, and increase 
lipid peroxidase within human epidermal cells.30 This indicates that titanium dioxide 
nanoparticles induce oxidative stress within the cell.
As further recognition of the known differences between macroscale material and nanoscale 
material, the United States Environmental Protection Agency (EPA) noted under the Toxic 
Substances Control Act (TSCA) that carbon nanotubes are distinct chemical substances 
different from other forms of carbon (e.g., graphite).31
At present, there are no enforceable national or international occupational exposure 
standards specific to engineered nanomaterials. NIOSH published a recommended exposure 
limit (REL) of 0.3 mg/m3 for ultrafine titanium dioxide.32 NIOSH also has issued a draft 
REL of 7 μg/m3 for carbon nanotubes and carbon nanofibers, measured as elemental carbon 
(EC), for an 8-h respirable-mass airborne concentration.
OELs for macroscale materials are often expressed as a concentration, such as μg/m3, which 
may not be appropriate or even measurable for nanoscale materials. The current draft 
NIOSH REL of 7 μg/m3 EC for an 8-h respirable-mass airborne concentration is based on 
the lowest airborne EC concentration that can be accurately measured by NIOSH method 
5040, but it has been noted that adverse lung effects have the potential to occur with 
exposure levels below this recommended level. In addition, whereas the NIOSH RELs are 
mass-based, current research indicates that mass and bulk chemistry may be less important 
than particle number, size and shape, surface area, and surface chemistry (or activity) as 
indicators of biologic activity for some nanostructured materials.10–12,18 Research is 
ongoing with regard to the relative importance of these different exposure metrics and how 
to best characterize exposures to nanomaterials in the workplace.9
Given this uncertainty and the growing body of literature on engineered nanomaterials, it is 
important to effectively communicate useful hazard information in a manner that is 
informative and protective and to give risk managers information that will assist them in 
making prudent risk management decisions. A survey conducted in 2007 by researchers at 
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the University of Massachusetts, Lowell, indicated that MSDSs from suppliers are the 
preferred source of risk information for nanotechnology firms.33
This report presents findings from the review of a small collection of MSDSs for engineered 
nanomaterials to evaluate the effectiveness of those data sheets in accomplishing the goal of 
providing both workers and managers with the most accurate health and safety information 
on nanomaterials.
METHODS
Obtaining Material Safety Data Sheets
A sample of 59 MSDSs specific to engineered nanomaterials (neat nanomaterials or 
chemical mixtures containing a nanomaterial, not including nanoengineered composites or 
finished goods) was obtained from 32 manufacturers by means of Internet search engines 
during 2007–2008. In 2010–2011, a random sample of an additional 21 MSDSs specific to 
engineered nanomaterials was obtained. In addition, 23 of the original 2007–2008 
nanomaterial MSDSs were re-collected in 2010–2011 for comparison purposes to determine 
whether improvements and revisions had occurred. These MSDSs were obtained with use of 
Internet search engines, as well as verbal and written requests, and were all evaluated on the 
basis of the same ranking scheme.
Reviewing Material Safety Data Sheets
The MSDSs were evaluated by means of a set of basic questions intended to determine 
whether their content was informative and protective, specifically as it pertains to hazard 
identification, exposure controls, PPE, and toxicological information. MSDSs were 
categorized according to the following four questions:
1. Did the MSDS indicate that the material is in the nanometer size range (<100 nm) 
by using numerical references or ranges?
2. Did the MSDS contain an OEL for the larger or bulk form (macroscale) of the 
material, and was there any guidance given on whether this OEL may or may not 
be protective for the nanomaterial?
3. Did the MSDS include specific toxicological data or information on the 
nanomaterial or indicate that nanomaterials may have different toxicities than 
larger particles of the same material?
4. Did the MSDS advise the use of protective measures, such as engineering controls, 
appropriate respiratory protection, and non-permeable gloves, when there is the 
potential for exposure?
The following paradigm was used to evaluate the collected MSDSs:
• If the MSDS was deficient in only one of the above categories, it was classified as 
satisfactory.
• If it was deficient in two categories, it was classified as in need of improvement.
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• If it was deficient in more than two categories, it was classified as in need of 
significant improvement.
Statistical Analysis
MSDSs produced by the same manufacturer are likely to have the same language and 
similar information. The resulting lack of statistical independence among such data sheets 
would invalidate commonly used tests for statistical significance.34 This issue was addressed 
by randomly choosing one MSDS per manufacturer when multiple MSDSs were available.
Descriptive statistics and tests were performed with use of Graph Pad-QuickCalcs software 
(http://www.graphpad.com/quickcalcs/index.cfm).35 Proportions were compared with 2 μ 2 
tables and Fisher’s exact test. All tests were 1-tailed and used an α of 0.05.
RESULTS
Study Sample
Fifty-nine MSDSs from 32 different manufacturers were initially obtained in 2007–2008. 
For purposes of this study, duplicates were removed and only one product per manufacturer 
was randomly identified for analysis, leaving 32 MSDSs for this evaluation. In the 2010–
2011 period, 65 MSDSs were originally obtained. Duplicates were removed, and only one 
product per manufacturer was randomly identified for analysis, leaving 21 original MSDSs 
and 23 for comparison with the 2007–2008 MSDSs. A total of 44 independent 
manufacturers’ MSDSs were available following the 2010– 2011 search. Table 1 provides a 
summary of the characteristics of each MSDS and the answers obtained from the four 
categorization questions.
Categorization of MSDSs
Categorization of the effectiveness of the 2007–2008 MSDSs concluded that 21.8% were 
satisfactory, 40.6%were in need of improvement, and 37.5% were in need of significant 
improvement. The most common deficiencies noted in the 2007–2008 MSDSs were the lack 
of toxicological data specific to the nanomaterial and the failure either to identify the 
material as being nanometer-sized or to list a particle size distribution showing the size 
range. Both deficiencies were noted in 26 (81.3%) of the 2007–2008 MSDSs. Nineteen 
(59.4%) of the MSDSs contained OELs for the bulk material without providing guidance on 
the ability of the OEL to protect against the nanoscale material. Twenty-two (68.8%) of the 
MSDSs recommended control of dust through either the use of engineering controls or the 
use of appropriate respirators and non-permeable gloves.
A total of 23 of the 32 nanomaterial MSDSs originally obtained in 2007– 2008 were 
recollected in 2010–2011 (several of the initial 32 manufacturers no longer had an Internet 
address). The 2010–2011 updated MSDSs were categorized as follows: four (17.4%) were 
ranked satisfactory, eight (34.8%) were ranked in need of improvement, and 11 (47.8%) 
were ranked in need of significant improvement. Comparison with the original MSDS data 
obtained for the same products/manufacturers showed an overall decrease in the percent of 
MSDSs ranked satisfactory or in need of improvement and an increase in the number of 
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MSDSs ranked in need of significant improvement. This could be because some of the more 
accurate MSDSs produced in 2007–2008 were not available in 2010–2011. The difference in 
the number of MSDSs that were ranked satisfactory was not statistically significant (p = 
0.6615). A comparison of the results for each of the four questions asked about each MSDS 
indicated that the changes noted in the MSDSs between 2007–2008 and 2010–2011 were not 
statistically significant.
The most common deficiency in the 21 new MSDSs (from 2010 to 2011) was a failure to 
specify that the material is in the nanometer size range (<100 nm) by using numerical 
references or ranges; this occurred in 17 (81.0%) of the MSDSs. Additionally, 15 (71.4%) of 
the MSDSs failed to include toxicological data or information specific to the nanomaterial or 
to reference that nanomaterials may have different toxicities than larger particles of the same 
material. A comparison of the 21 independent 2010–2011 MSDSs to the 32 independent 
2007–2008 MSDSs indicated that there was an overall increase in the number of MSDSs 
ranked as satisfactory and a decrease in those ranked in need of improvement or in need of 
significant improvement. The difference in the number of MSDSs ranked satisfactory was 
not a statistically significant improvement (p = 0.5439). Comparison of the results for each 
of the four answers sought within each MSDS 59.4% indicated that the changes noted in the 
information available were not statistically significant, with one exception. Ninety-five 
percent of MSDSs from 2010 to 2011 recommended using engineering controls and/or 
personal protective equipment to protect workers handling nanomaterials, which was found 
to be a statistically significant improvement (p = 0.0478). The mean review and/or revision 
date for the 2010–2011 MSDSs was 2009, which could indicate that companies had 
reviewed current information about the potential health effects of nanomaterial exposure 
before they updated the MSDSs.
There was no relationship between language addressing the four questions used in this study 
and the date on which the information in the MSDS had last been reviewed or updated. It 
was not clear whether a literature review had been performed as part of the last review date 
listed on the MSDSs. Eleven (47.8%) of the 2007–2008 versus 2010–2011 comparison 
MSDSs had not been updated since the year 2007. Five (21.7%) of the 2007–2008 versus 
2010–2011 comparisons had both no change in status and no revision date listed.
The majority of the MSDSs provided insufficient information for communicating the 
potential hazards of engineered nanomaterials. Table 2 summarizes the percent rankings of 
satisfactory, in need of improvement, and in need of significant improvement with the 2007–
2008, 2010–2011, and 2007–2008 versus 2010–2011 comparison MSDSs.
In addition to reviews of data sheet content against the questions developed for this 
evaluation, some of the language used to communicate possible safety or hazard issues was 
evaluated. MSDS statements considered vague and ineffective included the following:
• “There are no reports of adverse health effects on this material from customers and 
operators in our plant.”
• “No known toxicological effects.”
• “We are not aware of any reported health hazards for this product.”
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• “Non-hazardous.”
• “Hazard description – not applicable.”
These statements would seem to indicate that current research on nanomaterials was not 
reviewed by the manufacturer prior to making the MSDS available for employee and 
customer use.
DISCUSSION
The overwhelming majority of MSDSs did not clearly communicate the potential hazards of 
engineered nanoparticles in a way that was informative and protective. Of the reviewed 
MSDSs, 61% of those representing a mixture failed to identify which of the ingredients were 
nanosized. The nanoscale ingredient was made clearly evident in single-chemical MSDSs, 
but it was difficult to discern nanoscale ingredients in MSDSs pertaining to mixtures. More 
than half of the MSDSs included or referred to OELs for the bulk or larger-sized form of the 
chemical in question, even though the MSDSs pertained to the nanoscale version of the 
chemical. One half of the 26 MSDSs for carbonaceous materials (carbon nanotubes, carbon 
nanofibers, and fullerenes) referred to the OSHA OEL for the respirable fraction of synthetic 
graphite (5 mg/m3), carbon black (3.5 mg/m3), or for total nuisance particulates (15 mg/m3) 
without any indication that these may not be fully protective. Three (11.5%) of the MSDSs 
for carbonaceous materials indicated that there was no OEL available, and 10 (38.5%) made 
no reference whatsoever to an OEL. Referencing the bulk chemical exposure limit or the 
total particulate exposure limit in the absence of supporting data or conditional language 
may be misleading because there is currently no evidence to suggest that these levels are 
protective for the nanoscale material.
Many nanomaterial MSDSs also lacked toxicological data or listed toxicological data for the 
respective bulk substance. This may suggest that the same toxicological effects occur for 
both forms of the chemical, which may not necessarily be true. Knowledge of the size of 
particles that employees are being exposed to could assist in the selection of appropriate 
personal protection or engineering controls as well as provide a better understanding of 
potential health effects and risks.
This study is limited by a small sample size. Although there are many product MSDSs that 
contain information on nanomaterials, MSDSs produced by the same manufacturer are 
likely to have the same language and similar information. Because of this, the approach of 
randomly selecting one MSDS per manufacturer from among multiple available MSDSs was 
taken to render each MSDS statistically independent. The sample size in a survey can affect 
the precision of an estimate of prevalence.32 The final 2010–2011 sample size of 44 MSDSs 
(23 updated and 21 new) indicated a 25% prevalence of the satisfactory ranking. With an α 
of 0.05, the population of MSDSs yields a precision of ±12.6%. This indicates that if all 
nanomaterial MSDSs were reviewed, the prevalence of a satisfactory ranking would be 
between 12% and 38%. Even if 38% of the MSDSs were found to be ranked as satisfactory, 
there is still a 62% possibility that an individual using the information on the MSDS in the 
workplace may not be adequately informed or protected, because of a lack of knowledge 
regarding safety practices, toxicology, or health effects of the product.
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CONCLUSIONS
In conclusion, this study revealed that important information is not being developed or 
included on current nanomaterial MSDSs. The consequences of not providing adequate 
information is that workers may have exposure to nanomaterials that are known to have the 
potential to cause cellular damage and respiratory and pulmonary disease in animal studies, 
and that may migrate to other areas of the body following inhalation or dermal 
exposure.19,20,22–26,30 If workers are not able to obtain accurate, up-to-date information 
from the MSDS related to the nanomaterial in use, they may be less likely to use appropriate 
engineering controls or PPE to reduce exposures that pose health risks. In addition, when the 
employer’s primary source of information is an MSDS that fails to indicate a potential 
hazard to employees, then the employer may not be willing to integrate appropriate 
engineering controls or enforce the use of PPE.
In preparing MSDSs for engineered nanoparticles, product manufacturers should address the 
degree of current knowledge and all potential concerns that employees and/or health and 
safety personnel may have. It is recommended that MSDSs for engineered nanomaterials 
include the following information:
1. manufacturer’s name and contact information,
2. chemical and common names of all hazardous ingredients,
3. physical/chemical characteristics of the agent or agents (for example, an indication 
that the material is or contains a nanomaterial and the particle size or particle size 
distribution of the nanomaterial),
4. carcinogenicity potential,
5. emergency and first aid measures,
6. primary routes of entry,
7. exposure limits established by OSHA, NIOSH, American Conference of 
Governmental Industrial Hygienists, or European Union communities (if there is no 
OEL for the nanomaterial, then indicate that the OELs for the macroscale bulk 
material should be considered minimally protective for the nanometersized 
material),
8. physical hazards and reactivity data, such as flammability or explosive reactivity,
9. health hazard data, such as medical symptoms or known diseases that can be 
aggravated by exposure,
10. precautions for handling and use, including appropriate hygienic practices and 
procedures for cleaning up leaks and spills (note that wet methods are preferred for 
cleanup of dry powder nanomaterials, and if a vacuum is used, it should be 
exhausted through a HEPA filter; dry sweeping and blowing of materials should be 
prohibited),
11. applicable control measures such as engineering controls, work practices, or PPE 
(for example, recommend that worker exposure be minimized by institution of a 
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program of engineering controls such as exhausted enclosures or local exhaust 
ventilations; by good work practices, such as separation of the handling area from 
the rest of the facility; or by use of PPE such as protective clothing, safety glasses 
or goggles, chemical-resistant gloves, and respirators selected on the basis of the 
NIOSH respirator selection logic36),
12. toxicological information (for instance, an explanation that the characteristics of 
nanoparticles, such as small particle size and increased surface area, may contribute 
to potentially greater toxicity and biological activity than larger particles of the 
same chemical composition; in addition, the most recent toxicity information from 
an annual or more frequent literature search [OSHA mandates that newly found 
information on chemical hazards be added to MSDSs within 3 months of 
discovering such information]),
13. transport information,
14. disposal information,
15. ecological information,
16. date of preparation.
MSDSs for nanomaterials can be improved by conducting an extensive scientific literature 
review on the nanomaterial. The emphasis of this review should be discovering the latest 
toxicologic data, epidemiological findings, measurement techniques, engineering controls, 
and regulatory status so that the MSDS can be revised with the best, most current data. This 
will provide MSDS users with a knowledge base that will allow them to develop effective 
precautionary measures to control exposure and protect worker safety and health. It would 
also be beneficial to cite the publications that particular revisions are based upon so that 
additional information can be easily accessed if needed. Until the completeness and 
accuracy of information on MSDSs are ensured, the safety and health of workers using 
nanomaterial products cannot be fully protected.
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Figure 1. 
Electron Photomicrograph of a Carbon Nanotube and Carbon Nanofiber at 15,000× 
Magnification.
Eastlake et al. Page 14
Chem Health Saf. Author manuscript; available in PMC 2016 January 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Electron Photomicrograph of Carbon Black at 53,000× Magnification.
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Table 1
Characteristics and Summary of Questions Addressed in MSDSs.
MSDS Characteristic Number (%) of MSDSs
2007–2008
n = 32
2010–2011
n = 21
2010–2011,
Updated from
2007–2008
n = 23
Contained bulk OEL (macroscale)a 19 (59.4%) 16 (76.2%) 11 (47.8%)
Specified that material is nanometer range, using numbersb 6 (18.8%) 4 (19.0%) 6 (26.1%)
Specified nanomaterial toxicological data for productc 6 (18.8%) 6 (28.6%) 3 (13.0%)
Advised using engineering controls and/or PPEd 22 (68.8%) 20 (95.2%) 15 (65.2%)
No original or revision date 7 (22.0%) 2 (9.5%) 3 (13.0%)
Year of last review: mean (median), range 2005 (2005), 2009 (2010), 2008 (2008),
2003–2008 2005–2011 2004–2011
a
Did the MSDS contain an OEL for the larger or bulk form (macroscale) of the material, and was there any guidance given on whether this OEL 
may or may not be protective for the nanomaterial?
b
Did the MSDS indicate that the material is in the nanometer size range (<100 nm), using numerical references or ranges?
c
Did the MSDS include specific toxicological data or information for the nanomaterial or reference that nanomaterials may have different toxicities 
than larger particles of the same material?
d
Did the MSDS advise the useofengineering controls and/or appropriate respiratory protection (e.g., N95 or P100) and nonpermeable gloves when 
the potential for exposure exists?
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Table 2
Summary of MSDS Ranking, Based on Simple Ranking Scheme.
MSDS: Date Collected Ranking: No. (%)
Satisfactory In Need of Improvement In Need of Significant Improvement
2007–2008, n = 32 7 (21.8) 13 (40.6) 12 (37.5)
2010–2011, n = 21 7 (33.3) 10 (47.6) 4 (19.1)
2007–2008, recollected
 in 2010–2011, n = 23
4 (17.4) 8 (34.8) 11 (47.8)
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